A phase I/randomized phase II study of MLN0128 v.s pazopanib in patients with locally advanced/unresectable and/or metastatic sarcoma: Alliance A091304 Meeting Abstract


Authors: Tap, W. D.; Mahoney, M. R.; Jaslowski, A. J.; Horvath, L. E.; Schwartz, G.
Abstract Title: A phase I/randomized phase II study of MLN0128 v.s pazopanib in patients with locally advanced/unresectable and/or metastatic sarcoma: Alliance A091304
Meeting Title: 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 15 Suppl.
Meeting Dates: 2016 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-05-20
Start Page: 586s
Language: English
ACCESSION: WOS:000404712500464
DOI: 10.1200/JCO.2016.34.15_suppl.TPS11073
PROVIDER: wos
Notes: Meeting Abstract: TPS11073 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William Douglas Tap
    372 Tap